Literature DB >> 25757141

ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA.

S Bravaccini1, M M Tumedei1, P Ulivi1, W Zoli1, D Calistri1, P Candoli2, D Amadori3, M Puccetti4.   

Abstract

OBJECTIVE: As the diagnosis of non-small cell lung cancer (NSCLC) is based on cytology in around 70% of cases, it is important to use the same material for molecular analyses. Fluorescence in situ hybridization (FISH) is the only approved test for the detection of the translocation and inversion of anaplastic lymphoma kinase (ALK), but the optimal procedures for the fixation or staining of the sample before FISH evaluation have not been established. We investigated whether ALK gene status determined by FISH in a prospectively enrolled case series of patients was affected by fixation and staining.
METHODS: One hundred and fifteen cytological samples were obtained by transbronchial needle aspiration (TBNA) or endobronchial ultrasound (EBUS)-TBNA from 109 patients with NSCLC. All samples were evaluated for epidermal growth factor receptor (EGFR) mutation by pyrosequencing and for ALK rearrangement by FISH. Specimens for ALK determination had been fixed with Cytofix(®) and/or Carnoy's solution or 10% formalin (cell blocks) and variously stained.
RESULTS: Sixteen (14%) of the 115 samples were mutated for EGFR and 99 (86%) showed wild-type EGFR status. Of these 115 samples, 79 (69%) were negative for echinoderm microtubule-associated protein like 4 (EML4)-ALK translocation, nine (8%) were positive and 27 (23%) were unevaluable. In particular, 19 (26%) of the 72 Papanicolaou-stained smears fixed with Cytofix were unevaluable because of inadequate samples or cell overlapping; neither of the two May-Grünwald-Giemsa-stained samples were evaluable. Ten of 17 smears used for rapid on-site evaluation (ROSE) and immediately post-fixed in Carnoy's solution or 80% alcohol were evaluable.
CONCLUSIONS: In this series, smears were unevaluable as a result of inadequate samples, cell overlapping or lack of fixation performed immediately after FNA.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  ALK translocation; EBUS-TBNA; FISH; cell fixation; cytological samples; non-small cell lung cancer

Mesh:

Substances:

Year:  2015        PMID: 25757141     DOI: 10.1111/cyt.12237

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  7 in total

Review 1.  Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.

Authors:  Roberto Chalela; Víctor Curull; César Enríquez; Lara Pijuan; Beatriz Bellosillo; Joaquim Gea
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials.

Authors:  Yangyang Xu; Bing Wan; Xi Chen; Ping Zhan; Yuan Zhao; Tianli Zhang; Hongbing Liu; Muhammad Zubair Afzal; Said Dermime; Steven N Hochwald; Paul Hofman; Hossein Borghaei; Dang Lin; Tangfeng Lv; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2019-08

3.  Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.

Authors:  Wenbin Li; Zhihui Zhang; Lei Guo; Tian Qiu; Yun Ling; Jian Cao; Huiqin Guo; Huan Zhao; Lin Li; Jianming Ying
Journal:  Oncotarget       Date:  2016-02-16

4.  Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology.

Authors:  Sara Ravaioli; Sara Bravaccini; Maria Maddalena Tumedei; Flavio Pironi; Piero Candoli; Maurizio Puccetti
Journal:  Oncotarget       Date:  2017-02-14

5.  Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.

Authors:  Justyna Kutkowska; Leon Strzadala; Andrzej Rapak
Journal:  Cancer Sci       Date:  2017-09-19       Impact factor: 6.716

6.  Comparison of PD-L1, EGFR, ALK, and ROS1 Status Between Surgical Samples and Cytological Samples in Non-Small Cell Lung Carcinoma.

Authors:  Zübeyde Ekin; Deniz Nart; Pınar Savaş; Ali Veral
Journal:  Balkan Med J       Date:  2021-09       Impact factor: 2.021

Review 7.  The role of EBUS-TBNA in lung cancer restaging and mutation analysis.

Authors:  Piergiorgio Muriana; Francesca Rossetti
Journal:  Mediastinum       Date:  2020-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.